BIO-key International Inc. BKYI
1.79
(0.25)
(12.25%)
as of 25 Sep
- Market cap
- $2.9M
- P/E
- 0.0×
Follow BKYI
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(137.69%) | (161.24%) | (106.71%) | (107.91%) | |
| (51.51%) | (84.61%) | (68.52%) | (67.07%) | ||
ROIC |
(47.66%) | (173.28%) | (149.28%) | (121.93%) | |
Return on Tangible Assets |
(492.04%) | (474.25%) | (491.39%) | (728.80%) | |
Average Days of Receivables |
55.45 | 75.05 | 88.69 | 94.34 | |
Free Cash Flow per Share |
(5.09) | (7.04) | (4.05) | (4.01) | |
Free Cash Flow |
(3.35) | (4.68) | (4.19) | (4.16) | |
Capital Expenditures |
0.00 | (0.01) | — | — | |
Piotroski F-Score |
4.00 | 3.00 | 3.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(36.55%) | (59.46%) | (58.60%) | (72.59%) | |
Accounts Receivable Turnover |
12.53 | 5.90 | 5.36 | 4.67 | |
Accounts Payable Turnover |
1.23 | 2.07 | 2.71 | 1.93 | |
Inventory Turnover |
3.49 | 3.67 | 4.22 | 3.61 | |
Average Days of Payables |
175.42 | 134.88 | 127.68 | 119.91 | |
Days of Inventory on Hand |
105.48 | 98.59 | 84.03 | 109.56 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
40.78% | 43.96% | 40.63% | 39.34% | |
Selling, General and Administrative Expense of Revenue |
99.12% | 105.81% | 96.05% | 91.09% | |
Share Based Compensation of Revenue |
3.13% | 2.81% | 2.25% | 2.32% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.79 | 0.65 | 0.63 | 0.69 | |
Depreciation/Fixed assets |
10.56 | 11.98 | 13.94 | 19.15 | |
Capex/Depreciation |
0.00 | (0.01) | 0.00 | 0.00 | |
Revenue per Share |
9.59 | 8.93 | 6.26 | 6.46 | |
Operating CF per Share |
(5.09) | (7.02) | (4.05) | (4.01) | |
Capex per Share |
0.00 | (0.02) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(67.34%) | (120.55%) | (102.32%) | (90.10%) |
Columns are period end dates